CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11,980 enrolled
Drug / intervention
mFOCUSother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03979495
NCT03979495N/ACompleted
CompareCT.gov

mFOCUS (Multilevel FOllow-up of Cancer Screening)

Massachusetts General Hospital·interventional·Posted Jun 7, 2019·Updated May 10, 2024

In Brief

A clinical study evaluating mFOCUS for Cancer. Completed, enrolled 11,980 participants across 2 sites.

Detailed Summary

To evaluate the effectiveness of the system, team and individual components of mFOCUS vs. standard care by conducting a 4-arm cluster randomized controlled trial (RCT) of individuals who are due for follow-up of an abnormal cancer screening test.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
CollaboratorsBrigham and Women's Hospital, Dartmouth-Hitchcock Medical Center

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 7, 2019
Enrollment StartAug 24, 2020
Primary CompletionApr 12, 2022
Study CompletionAug 10, 2022
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.1 years ago

Interventions

mFOCUSother

To evaluate the effectiveness of the system, team and individual components of mFOCUS vs. standard care by conducting a 4-arm cluster randomized controlled trial (RCT) of individuals who are due for follow-up of an abnormal screen.